Incyte Corporation P/E Ratio 2009–2025
Incyte Corporation reported 15.41 of price-to-earnings ratio for fiscal 2025. That was 96.7% lower than fiscal 2024. Compared with fiscal 2019, the change was -63.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 15.41 | -96.7% |
| FY 2024 | 460.47 | +1843.4% |
| FY 2023 | 23.69 | -55.2% |
| FY 2022 | 52.84 | +207.4% |
| FY 2021 | 17.19 | — |
| FY 2020 | — | — |
| FY 2019 | 42.60 | -65.8% |
| FY 2018 | 124.69 | — |
| FY 2017 | — | — |
| FY 2016 | 185.69 | -94.9% |
| FY 2015 | 3615.00 | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
| FY 2011 | — | — |
| FY 2010 | — | — |
| FY 2009 | — | — |
Source: Incyte Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open INCY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Incyte Corporation reported 15.41 of price-to-earnings ratio for fiscal 2025. That was 96.7% lower than fiscal 2024. Compared with fiscal 2019, the change was -63.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Incyte Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIncyte Corporation — frequently asked questions
What is Incyte Corporation's price-to-earnings ratio?
Incyte Corporation (INCY) reported price-to-earnings ratio of 15.41 for fiscal year 2025, per its SEC filings.
How has Incyte Corporation's price-to-earnings ratio changed over time?
Between fiscal 2009 and 2025, INCY's price-to-earnings ratio declined at roughly 28.9% per year (compound annual rate), from 3615.00 to 15.41.
Where does this data come from?
Figures are computed from Incyte Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More INCY financial history
Full INCY fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →